DK1226131T3 - Isoxazolcarboxamidderivater - Google Patents

Isoxazolcarboxamidderivater

Info

Publication number
DK1226131T3
DK1226131T3 DK00992436T DK00992436T DK1226131T3 DK 1226131 T3 DK1226131 T3 DK 1226131T3 DK 00992436 T DK00992436 T DK 00992436T DK 00992436 T DK00992436 T DK 00992436T DK 1226131 T3 DK1226131 T3 DK 1226131T3
Authority
DK
Denmark
Prior art keywords
carboxamide derivatives
isoxazole carboxamide
isoxazole
derivatives
carboxamide
Prior art date
Application number
DK00992436T
Other languages
Danish (da)
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Elena Poggesi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of DK1226131T3 publication Critical patent/DK1226131T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
DK00992436T 1999-10-18 2000-10-16 Isoxazolcarboxamidderivater DK1226131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002173A IT1314191B1 (it) 1999-10-18 1999-10-18 Derivati isossazolcarbossamidici
PCT/EP2000/010144 WO2001029015A2 (en) 1999-10-18 2000-10-16 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists

Publications (1)

Publication Number Publication Date
DK1226131T3 true DK1226131T3 (da) 2004-04-19

Family

ID=11383797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00992436T DK1226131T3 (da) 1999-10-18 2000-10-16 Isoxazolcarboxamidderivater

Country Status (25)

Country Link
EP (1) EP1226131B1 (it)
JP (1) JP2003512362A (it)
KR (1) KR20020038944A (it)
CN (1) CN1139579C (it)
AR (1) AR029400A1 (it)
AT (1) ATE256670T1 (it)
AU (1) AU757614B2 (it)
BR (1) BR0014851A (it)
CA (1) CA2385472A1 (it)
DE (1) DE60007347T2 (it)
DK (1) DK1226131T3 (it)
ES (1) ES2210033T3 (it)
HK (1) HK1044940A1 (it)
HU (1) HUP0203184A3 (it)
IL (1) IL148837A0 (it)
IT (1) IT1314191B1 (it)
MX (1) MXPA02003432A (it)
MY (1) MY120400A (it)
NO (1) NO20021803L (it)
NZ (1) NZ517884A (it)
PL (1) PL356990A1 (it)
PT (1) PT1226131E (it)
RU (1) RU2002113096A (it)
WO (1) WO2001029015A2 (it)
ZA (1) ZA200203942B (it)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009511533A (ja) 2005-10-11 2009-03-19 エフ．ホフマン−ラ ロシュ アーゲー イソオキサゾール誘導体
WO2007054444A2 (en) 2005-11-09 2007-05-18 F. Hoffmann-La Roche Ag 3-aryl-isoxazole-4-carbonyl-benzofuran derivatives
ES2397401T3 (es) 2005-12-23 2013-03-06 F. Hoffmann-La Roche Ag Derivados de aril-isoxazol-4-il-oxadiazol
AU2006331437B2 (en) 2005-12-27 2012-07-05 F. Hoffmann-La Roche Ag Aryl-Isoxazol-4-yl-Imidazole derivatives
BRPI0706560A2 (pt) 2006-01-17 2011-03-29 Hoffmann La Roche derivados de aril-isoxazol-4-il-imidazo [1,2-a] piridina úteis para o tratamento de doença de alzheimer por intermédio de receptores gaba
WO2007137954A1 (en) 2006-05-31 2007-12-06 F. Hoffmann-La Roche Ag Aryl-4-ethynyl-isoxazole derivatives
WO2009000662A1 (en) 2007-06-22 2008-12-31 F. Hoffmann-La Roche Ag Isoxazole-imidazole derivatives
US7902201B2 (en) 2007-12-04 2011-03-08 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
AU2008333320B2 (en) 2007-12-04 2012-12-20 F. Hoffmann-La Roche Ag Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
TW201033201A (en) 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US20100280019A1 (en) 2009-04-30 2010-11-04 Roland Jakob-Roetne Isoxazoles
KR101701533B1 (ko) 2009-05-05 2017-02-13 에프. 호프만-라 로슈 아게 아이속사졸-피리다진 유도체
KR101384829B1 (ko) 2009-05-05 2014-04-15 에프. 호프만-라 로슈 아게 이속사졸-피라졸 유도체
KR101354335B1 (ko) 2009-05-05 2014-02-19 에프. 호프만-라 로슈 아게 인지 장애의 치료에 사용되는 ｇａｂａ ａ 수용체 역 작용제로서의 아이속사졸-티아졸 유도체
CN102414206B (zh) 2009-05-05 2014-11-05 霍夫曼-拉罗奇有限公司 异*唑-吡啶衍生物
WO2010127978A1 (en) 2009-05-07 2010-11-11 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives as gaba modulators
US8785435B2 (en) 2011-10-20 2014-07-22 Hoffmann-La Roche Inc. Solid forms
CN113121540B (zh) * 2020-01-15 2024-01-26 鲁南制药集团股份有限公司 一种西格列汀游离碱的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
AU2834701A (en) 2001-04-30
HUP0203184A3 (en) 2004-12-28
IL148837A0 (en) 2002-09-12
NZ517884A (en) 2003-08-29
RU2002113096A (ru) 2003-11-10
WO2001029015A3 (en) 2001-11-01
CN1139579C (zh) 2004-02-25
CN1379767A (zh) 2002-11-13
DE60007347D1 (de) 2004-01-29
ITMI992173A1 (it) 2001-04-18
WO2001029015A2 (en) 2001-04-26
NO20021803D0 (no) 2002-04-17
NO20021803L (no) 2002-06-17
KR20020038944A (ko) 2002-05-24
DE60007347T2 (de) 2004-09-02
ATE256670T1 (de) 2004-01-15
HUP0203184A2 (hu) 2003-01-28
AU757614B2 (en) 2003-02-27
CA2385472A1 (en) 2001-04-26
HK1044940A1 (zh) 2002-11-08
MXPA02003432A (es) 2002-08-20
ZA200203942B (en) 2003-01-02
ITMI992173A0 (it) 1999-10-18
EP1226131A2 (en) 2002-07-31
BR0014851A (pt) 2002-06-11
ES2210033T3 (es) 2004-07-01
PL356990A1 (en) 2004-07-12
EP1226131B1 (en) 2003-12-17
IT1314191B1 (it) 2002-12-06
MY120400A (en) 2005-10-31
JP2003512362A (ja) 2003-04-02
PT1226131E (pt) 2004-05-31
AR029400A1 (es) 2003-06-25

Similar Documents

Publication Publication Date Title
DK1226131T3 (da) Isoxazolcarboxamidderivater
NO20000885D0 (no) 4-Fenyl-pyridin-derivater
ATE266023T1 (de) Amid-derivate
NO20021077D0 (no) Amino-triazolopyridin-derivater
ATE263748T1 (de) Admantan-derivate
ATE293104T1 (de) Thiazolylamid-derivate
IS6128A (is) 13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da) 5-phenyl-pyrimidinderivater
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
PT1237857E (pt) Novos derivados fenalquiloxi-fenilo
ATE257148T1 (de) Propargyletherderivate
DK1154988T3 (da) Mevinolinderivater
ATE374747T1 (de) Monofluoralkylderivate
DE60006703D1 (de) 4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da) 4-phenyl-pyrimidinderivater
ATE293592T1 (de) Resorcinderivate
NO20020212D0 (no) 3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no) Syklopentenon-derivater
DK1189886T3 (da) Ethansulfonyl-piperidinderivater
DE60001736D1 (de) 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
DE59909774D1 (de) 1-cycloalkylpyrazolyl-benzoyl-derivate
DE50009514D1 (de) Oxazolidinon-derivate